Source: Eur Respir J, 54 (5) 1902034; 10.1183/13993003.02034-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mina Gaga, Eleftherios Zervas. Oral steroids in asthma: a double-edged sword. Eur Respir J, 54 (5) 1902034; 10.1183/13993003.02034-2019

Member's Comments

No comment yet.

Related content which might interest you: A double-edged sword Source: Breathe, 16 (3) 200017; 10.1183/20734735.0017-2020 Year: 2020 The double-edged sword of neutrophilic inflammation in bronchiectasis Source: Eur Respir J 2015; 46: 898-900 Year: 2015 Inhaled corticosteroids in COPD: friend or foe? Source: Eur Respir J, 52 (6) 1801219; 10.1183/13993003.01219-2018 Year: 2018 What is the role of oral corticosteroids in the era of biologics in asthma? Source: International Congress 2019 – State of the art session: Airway disease Year: 2019 Double edge sword: antibiotics in the prevention and treatment of COPD exacerbation Source: Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session Year: 2012 Late Breaking Abstract - Overuse of oral corticosteroids in asthma – modifiable factors and potential role of biologics Source: International Congress 2019 – Novel findings from asthma clinical trials Year: 2019 How effective are oral steroids in asthma action plans? Source: International Congress 2017 – Asthma management Year: 2017 Conclusion: new endogeneous anti-inflammatory pathways in asthma and COPD Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 LSC - 2019 - Interleukin-33: a double-edged sword in mast cell responses to rhinovirus infection Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Macrolide therapy for patients with pneumonia: a triple-edged sword Source: Eur Respir Monogr 2017; 75: 206-231 Year: 2017 Oral corticosteroid prescription in asthma: Swiss situation Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Asthma progression and mortality: the role of inhaled corticosteroids Source: Eur Respir J, 54 (1) 1900491; 10.1183/13993003.00491-2019 Year: 2019 Inhaled therapies: can they breathe new life into asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019 Year: 2020 Anti-inflammatory therapy COPD: fenspiride and(or) theophylline versus inhaled corticosteroids? Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Late Breaking Abstract - Two-year cumulative oral corticosteroid exposure in severe eosinophilic asthma before and after anti-IL-5 therapy Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021